ClinConnect ClinConnect Logo
Search / Trial NCT03824548

Outcomes for Patients With Gastro-Esophageal Reflux Disease

Launched by TIANJIN HAPPY LIFE TECHNOLOGY CO., LTD. · Jan 29, 2019

Trial Information

Current as of June 19, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Medical records of GERD, NERD and/or EE diagnoses (ICD code scope will be confirmed later)from January 1st, 2015 to December 31st, 2017.
  • oGERD is typically characterized by symptoms of heartburn and acid regurgitation. A diagnosis of EE or NERD can only be confirmed upon endoscopic examination.
  • All ages, males or females
  • A primary diagnosis of GERD/NERD/EE
  • For treatment patterns, patients are also required to have received one episode of treatment during the analysis period.
  • For RW treatment efficacy, the population will be restricted to the EE treatment population who underwent at least two endoscopy examinations.
  • Exclusion Criteria:
  • - No exclusion criteria will be applied for investigating diagnosis since all patients diagnosed with GERD, NERD, or EE should be captured regardless of whether they have medical conditions that affect their treatments.
  • A patient will not be eligible for investigating treatment patterns and RW treatment efficacy if he/she has any of the following exclusion criterion:
  • A post-operative diagnosis of gastrointestinal cancers
  • A diagnosis of esophageal foreign bodies or neoplasms
  • A history of gastric or esophageal surgery
  • Zollinger-Ellison syndrome
  • Primary esophageal motility disorders (ex: achalasia)
  • Esophageal strictures
  • Eosinophilic esophagitis
  • Identified as pregnant or lactating
  • Hospitalized (inpatient) patients (to be confirmed by expert.) due to GERD as primary or secondary diagnosis

About Tianjin Happy Life Technology Co., Ltd.

Tianjin Happy Life Technology Co., Ltd. is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on improving patient outcomes, the company specializes in the design, execution, and management of clinical trials across various therapeutic areas. Leveraging state-of-the-art technology and a commitment to regulatory compliance, Tianjin Happy Life Technology collaborates with healthcare professionals and institutions to ensure high-quality data collection and analysis. Their mission is to contribute to the global advancement of medical science while prioritizing patient safety and ethical standards in all research activities.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials